Working… Menu

University of Washington Reading & Dyslexia Research Program

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03945097
Recruitment Status : Unknown
Verified May 2019 by Jason Yeatman, University of Washington.
Recruitment status was:  Recruiting
First Posted : May 10, 2019
Last Update Posted : May 10, 2019
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by (Responsible Party):
Jason Yeatman, University of Washington

Brief Summary:
Subjects are recruited for a pre-kindergarten education program focusing on early literacy skills. Primary outcomes are improvement in letter knowledge and changes in brain response to text.

Condition or disease Intervention/treatment
Reading Disability Behavioral: preK

Layout table for study information
Study Type : Observational
Estimated Enrollment : 44 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: University of Washington Reading & Dyslexia Research Program
Estimated Study Start Date : May 2019
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2021

Group/Cohort Intervention/treatment
Education program focuses on learning letters.
Behavioral: preK
Subjects enter and education program that either focuses on learning letters and their corresponding sounds or on language comprehension skills.

Education program focuses on language comprehension.

Primary Outcome Measures :
  1. Letter Knowledge [ Time Frame: Within 2 weeks post intervention ]
    Knowledge of letter names and sounds. This is computed as percent correct (out of 52). Each child is shown a flash card with each upper case letter and asked to name it and say its sound

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   60 Months to 72 Months   (Child)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Typically developing children

Inclusion Criteria: Typically developing children enrolled before kindergarten.

  • Typically developing child between 60 and 72 months of age
  • Has not yet begun Kindergarten

Exclusion Criteria:

  • Reported neurological or psychiatric condition.
  • Claustrophobia. ADHD

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03945097

Layout table for location contacts
Contact: Patrick Donnelly 206-685-9365

Layout table for location information
United States, Washington
University of Washignton Recruiting
Seattle, Washington, United States, 98195
Contact: Jason Yeatman, PhD         
Sponsors and Collaborators
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Layout table for investigator information
Principal Investigator: Jason Yeatman, PhD University of Washington
Layout table for additonal information
Responsible Party: Jason Yeatman, Assistant Professor, Institute for Learning & Brain Sciences, Dept. of Speech & Hearing Services, University of Washington Identifier: NCT03945097    
Other Study ID Numbers: STUDY00000516
1R21HD092771-01A1 ( U.S. NIH Grant/Contract )
First Posted: May 10, 2019    Key Record Dates
Last Update Posted: May 10, 2019
Last Verified: May 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Language Disorders
Communication Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Learning Disorders
Neurodevelopmental Disorders
Mental Disorders